SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001172661-24-005063
Filing Date
2024-11-14
Accepted
2024-11-14 15:10:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 cormorant-lbph093024a4.htm SC 13G/A 84857
  Complete submission text file 0001172661-24-005063.txt   86554
Mailing Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 857-702-0388
Cormorant Asset Management, LP (Filed by) CIK: 0001583977 (see all company filings)

IRS No.: 462108927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037 619-592-9775
Longboard Pharmaceuticals, Inc. (Subject) CIK: 0001832168 (see all company filings)

IRS No.: 845009619 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92379 | Film No.: 241460811
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)